Clinical Trial Update: Phase II Randomized Trial:Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers [Phase 2]

View source ↗

Summary

Phase II randomized trial evaluating arginine butyrate plus standard local therapy for refractory sickle cell ulcers; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease
• Skin Ulcers

Drugs mentioned

• Arginine butyrate (arginine butyrate)

Snippet

Sponsor: Susan P. Perrine | Conditions: Skin Ulcers, Sickle Cell Anemia | Phase 2 | Status: COMPLETED | Results posted: 2015-03-31